Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients

Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients

Abstract Background Whether adjuvant chemotherapy (AC) after concurrent chemoradiotherapy (CCRT) could provide benefit to esophageal squamous cell carcinoma (ESCC) patients is controversial. Therefore, we decided to investigate the potential benefit of AC after CCRT for ESCC and to identify biomarke...

Full description

Bibliographic Details
Main Authors: Ao Liu, Yalin Wang, Xin Wang, Liqiong Zhu, Yu Nie, Minghuan Li
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Radiation Oncology
Subjects:
Esophageal cancer
Radiotherapy
Adjuvant chemotherapy
Prediction
Online Access:https://doi.org/10.1186/s13014-021-01921-3

Internet

https://doi.org/10.1186/s13014-021-01921-3

Similar Items